HIF-1α silencing suppresses growth of lung adenocarcinoma A549 cells through induction of apoptosis

Molecular Medicine Reports

Volumn 9, Issue 3, 2014, Pages 911-915

  Liao, Hong Ying ^a   Wang, Gui Ping ^b   Huang, Shao Hong ^a   Li, Yun ^a   Cai, Song Wang ^a   Zhang, Jian ^a   Chen, Hui Guo ^a   Wu, Wei Bin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

HIF 1 ; Lung adenocarcinoma; RNA interference; Target therapy

Indexed keywords

ADENOCARCINOMA; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG NEOPLASMS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84893832703     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.1910     Document Type: Article

References (24)

1. Kadara H, Kabbout M and Wistuba II: Pulmonary adenocarcinoma: a renewed entity in 2011. Respirology 17: 50-65, 2012.
2. Travis WD, Brambilla E, Noguchi M, et al; American Thoracic Society: International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc 8: 381-385, 2011.
3. Hodkinson PS and Sethi T: Advances in the prevention and treatment of lung cancer. J R Coll Physicians Edinb 41: 142-149, 2011.
4. Mitsudomi T and Yatabe Y: Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer. Cancer Sci 98: 1817-1824, 2007.
5. de Mello RA, Marques DS, Medeiros R and Araújo AM: Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies. World J Clin Oncol 2: 367-376, 2011.
6. Moran C: Importance of molecular features of non-small cell lung cancer for choice of treatment. Am J Pathol 178: 1940-1948, 2011.
7. Patiar S and Harris AL: Role of hypoxia-inducible factor-1alpha as a cancer therapy target. Endocr Relat Cancer 13 (Suppl 1): S61-S75, 2006.
8. Savai R, Schermuly RT, Voswinckel R, et al: HIF-1α attenuates tumor growth in spite of augmented vascularization in an A549 adenocarcinoma mouse model. Int J Oncol 27: 393-400, 2005.
9. Scortegagna M, Martin RJ, Kladney RD, Neumann RG and Arbeit JM: Hypoxia-inducible factor-1alpha suppresses squamous carcinogenic progression and epithelial-mesenchymal transition. Cancer Res 69: 2638-2646, 2009.
10. Sinha I, Null K, Wolter W, et al: Methylseleninic acid downregulates hypoxia-inducible factor-1α in invasive prostate cancer. Int J Cancer 130: 1430-1439, 2012.
11. Wan J, Chai H, Yu Z, et al: HIF-1α effects on angiogenic potential in human small cell lung carcinoma. J Exp Clin Cancer Res 30: 77, 2011.
12. Hannon GJ: RNA interference. Nature 418: 244-251, 2002.
13. Volm M and Koomägi R: Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res 20: 1527-1533, 2000.
14. Swinson DE, Jones JL, Cox G, et al: Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways. Int J Cancer 111: 43-50, 2004.
15. Shyu KG, Hsu FL, Wang MJ, Wang BW and Lin S: Hypoxia-inducible factor 1alpha regulates lung adenocarcinoma cell invasion. Exp Cell Res 313: 1181-1191, 2007.
16. Luo F, Liu X, Yan N, et al: Hypoxia-inducible transcription factor-1alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway. BMC Cancer 6: 26, 2006.
17. Liao HY, Wang GP, Gu LJ, et al: HIF-1α siRNA and cisplatin in combination suppress tumor growth in a nude mice model of esophageal squamous cell carcinoma. Asian Pac J Cancer Prev 13: 473-477, 2012.
18. Wang G, Ye Y, Yang X, Liao H, Zhao C and Liang S: Expression-based in silico screening of candidate therapeutic compounds for lung adenocarcinoma. PLoS One 6: e14573, 2011.
19. Xu K, Ding Q, Fang Z, et al: Silencing of HIF-1alpha suppresses tumorigenicity of renal cell carcinoma through induction of apoptosis. Cancer Gene Ther 17: 212-222, 2010.
20. Kurokawa T, Miyamoto M, Kato K, et al: Overexpression of hypoxia-inducible-factor 1alpha(HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Br J Cancer 89: 1042-1047, 2003.
21. Theodoropoulos GE, Lazaris AC, Theodoropoulos VE, et al: Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer. Int J Colorectal Dis 21: 248-257, 2006.
22. Flamant L, Notte A, Ninane N, Raes M and Michiels C: Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia. Mol Cancer 9: 191, 2010.
23. Yook YJ, Seo YJ, Kang HJ, et al: Induction of hypoxia-inducible factor-1α inhibits drug-induced apoptosis in the human leukemic cell line HL-60. Korean J Hematol 45: 158-163, 2010.
24. Olsson M and Zhivotovsky B: Caspases and cancer. Cell Death Differ 18: 1441-1449, 2011.